WO2011011302A3 - Differentiation of human embryonic stem cells - Google Patents

Differentiation of human embryonic stem cells Download PDF

Info

Publication number
WO2011011302A3
WO2011011302A3 PCT/US2010/042393 US2010042393W WO2011011302A3 WO 2011011302 A3 WO2011011302 A3 WO 2011011302A3 US 2010042393 W US2010042393 W US 2010042393W WO 2011011302 A3 WO2011011302 A3 WO 2011011302A3
Authority
WO
WIPO (PCT)
Prior art keywords
differentiation
stem cells
embryonic stem
human embryonic
present
Prior art date
Application number
PCT/US2010/042393
Other languages
French (fr)
Other versions
WO2011011302A2 (en
Inventor
Jean Xu
Original Assignee
Centocor Ortho Biotech Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43465585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2011011302(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to RU2012105923/10A priority Critical patent/RU2540021C2/en
Priority to KR1020177028099A priority patent/KR101893021B1/en
Priority to CN201080033697.2A priority patent/CN102482640B/en
Priority to EP10802710.3A priority patent/EP2456858B1/en
Priority to PL10802710T priority patent/PL2456858T3/en
Priority to JP2012521699A priority patent/JP5819825B2/en
Priority to CA2768644A priority patent/CA2768644A1/en
Priority to SG2012000220A priority patent/SG177483A1/en
Priority to BR112012001557A priority patent/BR112012001557A2/en
Priority to MX2012000899A priority patent/MX340952B/en
Priority to KR1020127003776A priority patent/KR101785626B1/en
Priority to ES10802710.3T priority patent/ES2693088T3/en
Priority to GB1202847.8A priority patent/GB2485112B/en
Priority to AU2010276440A priority patent/AU2010276440B2/en
Application filed by Centocor Ortho Biotech Inc. filed Critical Centocor Ortho Biotech Inc.
Publication of WO2011011302A2 publication Critical patent/WO2011011302A2/en
Publication of WO2011011302A3 publication Critical patent/WO2011011302A3/en
Priority to ZA2012/01221A priority patent/ZA201201221B/en
Priority to HK12110883.5A priority patent/HK1170262A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0613—Cells from endocrine organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/19—Growth and differentiation factors [GDF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Abstract

The present invention provides methods to promote the differentiation of pluripotent stem cells into insulin producing cells. In particular, the present invention provides a method to produce cells capable of producing insulin following transplantation into an animal.
PCT/US2010/042393 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells WO2011011302A2 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
KR1020177028099A KR101893021B1 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
MX2012000899A MX340952B (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells.
BR112012001557A BR112012001557A2 (en) 2009-07-20 2010-07-19 differentiation of human embryonic stem cells.
EP10802710.3A EP2456858B1 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
PL10802710T PL2456858T3 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
JP2012521699A JP5819825B2 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
CA2768644A CA2768644A1 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
SG2012000220A SG177483A1 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
CN201080033697.2A CN102482640B (en) 2009-07-20 2010-07-19 Differentiation Of Human Embryonic Stem Cells
RU2012105923/10A RU2540021C2 (en) 2009-07-20 2010-07-19 Differentiating human embryonic stem cells
ES10802710.3T ES2693088T3 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
KR1020127003776A KR101785626B1 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
GB1202847.8A GB2485112B (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
AU2010276440A AU2010276440B2 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells
ZA2012/01221A ZA201201221B (en) 2009-07-20 2012-02-17 Differentiation of human embryonic stem cells
HK12110883.5A HK1170262A1 (en) 2009-07-20 2012-10-30 Differentiation of human embryonic stem cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22693609P 2009-07-20 2009-07-20
US61/226,936 2009-07-20

Publications (2)

Publication Number Publication Date
WO2011011302A2 WO2011011302A2 (en) 2011-01-27
WO2011011302A3 true WO2011011302A3 (en) 2011-05-05

Family

ID=43465585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/042393 WO2011011302A2 (en) 2009-07-20 2010-07-19 Differentiation of human embryonic stem cells

Country Status (18)

Country Link
US (1) US8785184B2 (en)
EP (1) EP2456858B1 (en)
JP (1) JP5819825B2 (en)
KR (2) KR101785626B1 (en)
CN (1) CN102482640B (en)
AR (1) AR077767A1 (en)
AU (1) AU2010276440B2 (en)
BR (1) BR112012001557A2 (en)
CA (1) CA2768644A1 (en)
ES (1) ES2693088T3 (en)
GB (1) GB2485112B (en)
HK (1) HK1170262A1 (en)
MX (1) MX340952B (en)
PL (1) PL2456858T3 (en)
RU (1) RU2540021C2 (en)
SG (1) SG177483A1 (en)
WO (1) WO2011011302A2 (en)
ZA (1) ZA201201221B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009154606A1 (en) * 2008-06-03 2009-12-23 Cythera, Inc. Growth factors for production of definitive endoderm
US20100272695A1 (en) * 2009-04-22 2010-10-28 Alan Agulnick Cell compositions derived from dedifferentiated reprogrammed cells
SG10201501503VA (en) 2010-03-01 2015-04-29 Janssen Biotech Inc Methods for purifying cells derived from pluripotent stem cells
US8835400B2 (en) 2010-10-08 2014-09-16 Mina Therapeutics Limited RNA molecules that upregulate insulin production
CN108220224A (en) * 2011-06-21 2018-06-29 诺沃—诺迪斯克有限公司 Definitive entoderm is effectively induced from pluripotent stem cell
JP6441080B2 (en) 2011-12-22 2018-12-19 ヤンセン バイオテツク，インコーポレーテツド Differentiation of human embryonic stem cells into single hormone insulin-positive cells
EP2859091B1 (en) * 2012-06-08 2018-08-29 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
JP6470687B2 (en) 2012-09-03 2019-02-13 ノヴォ ノルディスク アー／エス Production of pancreatic endoderm from pluripotent stem cells using small molecules
MX2015008619A (en) 2012-12-31 2016-01-12 Janssen Biotech Inc Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells.
WO2014105543A1 (en) 2012-12-31 2014-07-03 Janssen Biotech, Inc. Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
US8859286B2 (en) 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
DE202014011287U1 (en) 2013-06-11 2019-02-06 The President And Fellows Of Harvard College SC-β cells and compositions for producing the cells
KR102252561B1 (en) 2013-11-22 2021-05-20 미나 테라퓨틱스 리미티드 C/ebp alpha short activating rna compositions and methods of use
CN107614678B (en) 2014-12-18 2021-04-30 哈佛学院校长同事会 Method for producing stem cell-derived beta cells and method for using same
WO2016100898A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof
EP3234110B1 (en) 2014-12-18 2024-02-28 President and Fellows of Harvard College METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
AU2018370029A1 (en) 2017-11-15 2020-07-02 Vertex Pharmaceuticals Incorporated Islet cell manufacturing compositions and methods of use
WO2020033879A1 (en) 2018-08-10 2020-02-13 Semma Therapeutics, Inc. Stem cell derived islet differentiation
US10724052B2 (en) 2018-09-07 2020-07-28 Crispr Therapeutics Ag Universal donor cells
WO2020068984A1 (en) * 2018-09-25 2020-04-02 The Regents Of The University Of California Production and enrichment of pancreatic endocrine progenitor cells
WO2020243665A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
EP3976236A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. A biocompatible membrane composite
EP3976237A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. Cell encapsulation devices with controlled oxygen diffusion distances
EP3975926A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates, Inc. A biocompatible membrane composite
CA3150235A1 (en) 2019-09-05 2021-03-11 Alireza Rezania Universal donor cells
CN114364791A (en) 2019-09-05 2022-04-15 克里斯珀医疗股份公司 Universal donor cell
EP4271796A1 (en) 2020-12-31 2023-11-08 CRISPR Therapeutics AG Universal donor cells

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138948A1 (en) * 2001-12-07 2003-07-24 Fisk Gregory J. Islet cells from human embryonic stem cells
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
US20050054102A1 (en) * 2001-04-19 2005-03-10 Anna Wobus Method for differentiating stem cells into insulin-producing cells
US20050208029A1 (en) * 2002-04-17 2005-09-22 Akihiro Umezawa Method of forming pancreatic beta cells from mesenchymal cells
US20060281174A1 (en) * 2004-03-09 2006-12-14 Gang Xu Methods for generating insulin-producing cells

Family Cites Families (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3209652A (en) * 1961-03-30 1965-10-05 Burgsmueller Karl Thread whirling method
AT326803B (en) * 1968-08-26 1975-12-29 Binder Fa G MESHWARE AND METHOD OF MANUFACTURING THE SAME
US3935067A (en) * 1974-11-22 1976-01-27 Wyo-Ben Products, Inc. Inorganic support for culture media
US4499802A (en) * 1982-09-29 1985-02-19 Container Graphics Corporation Rotary cutting die with scrap ejection
US4537773A (en) * 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
US4557264A (en) * 1984-04-09 1985-12-10 Ethicon Inc. Surgical filament from polypropylene blended with polyethylene
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4737578A (en) * 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5759830A (en) 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
US5567612A (en) 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
EP0363125A3 (en) 1988-10-03 1990-08-16 Hana Biologics Inc. Proliferated pancreatic endocrine cell product and process
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5449383A (en) * 1992-03-18 1995-09-12 Chatelier; Ronald C. Cell growth substrates
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
CA2114282A1 (en) * 1993-01-28 1994-07-29 Lothar Schilder Multi-layered implant
JP3525221B2 (en) 1993-02-17 2004-05-10 味の素株式会社 Immunosuppressants
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
GB9310557D0 (en) * 1993-05-21 1993-07-07 Smithkline Beecham Plc Novel process and apparatus
TW257671B (en) * 1993-11-19 1995-09-21 Ciba Geigy
US5834308A (en) * 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US6001647A (en) * 1994-04-28 1999-12-14 Ixion Biotechnology, Inc. In vitro growth of functional islets of Langerhans and in vivo uses thereof
US6703017B1 (en) * 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
WO1996020728A1 (en) 1994-12-29 1996-07-11 Chugai Seiyaku Kabushiki Kaisha Antitumor agent potentiator comprising il-6 antagonist
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5718922A (en) * 1995-05-31 1998-02-17 Schepens Eye Research Institute, Inc. Intravitreal microsphere drug delivery and method of preparation
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
KR100568438B1 (en) 1997-04-24 2006-04-07 오르토-맥네일 파마슈티칼, 인코퍼레이티드 Substituted imidazoles useful in the treatment of inflammatory diseases, a process for the preparation thereof and pharmaceutical compositions containing the same
AU8476698A (en) * 1997-07-03 1999-01-25 Osiris Therapeutics, Inc. Human mesenchymal stem cells from peripheral blood
US6670127B2 (en) * 1997-09-16 2003-12-30 Egea Biosciences, Inc. Method for assembly of a polynucleotide encoding a target polypeptide
EP1538206B1 (en) * 1997-09-16 2010-03-24 Centocor, Inc. Method for the complete chemical synthesis and assembly of genes and genomes
AU1197699A (en) 1997-10-23 1999-05-10 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells
US6372779B1 (en) 1997-12-29 2002-04-16 Ortho Pharmaceutical Corporation Anti-inflammatory compounds
ATE316795T1 (en) * 1998-03-18 2006-02-15 Osiris Therapeutics Inc MESENCHYMAL STEM CELLS FOR THE PREVENTION AND TREATMENT OF IMMUNE RESPONSE DURING TRANSPLANTATIONS
MY132496A (en) 1998-05-11 2007-10-31 Vertex Pharma Inhibitors of p38
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
CA2359159A1 (en) * 1999-01-21 2000-07-27 Vitro Diagnostics, Inc. Immortalized cell lines and methods of making the same
US6815203B1 (en) * 1999-06-23 2004-11-09 Joslin Diabetes Center, Inc. Methods of making pancreatic islet cells
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US6303424B1 (en) * 1999-10-21 2001-10-16 United Microelectronics Corp. Method for fabricating a buried bit line in a DRAM cell
US20030082155A1 (en) * 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US6753153B2 (en) * 1999-12-13 2004-06-22 The Scripps Research Institute Markers for identification and isolation of pancreatic islet α and β progenitors
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6436704B1 (en) * 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CN1449439A (en) * 2000-06-26 2003-10-15 株式会社雷诺再生医学研究所 Cell fraction containing cells capable of differentiating into nervous system cells
KR100850812B1 (en) 2000-10-23 2008-08-06 스미스클라인 비참 코포레이션 Novel Compounds
DK1362047T3 (en) 2000-12-08 2006-09-04 Ortho Mcneil Pharm Inc Indazolyl-substituted pyrroline compounds as kinase inhibitors
JP2004526676A (en) 2000-12-08 2004-09-02 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Large-membered heterocyclic compounds useful as kinase inhibitors
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
JP2005503759A (en) * 2001-01-24 2005-02-10 アメリカ合衆国 Differentiation of stem cells into pancreatic endocrine cells
DK1355910T3 (en) * 2001-01-25 2011-06-27 Us Of America Represented By The Secretary Dept Of Health And Human Services Formulation of boric acid compounds
US6656488B2 (en) 2001-04-11 2003-12-02 Ethicon Endo-Surgery, Inc. Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering
JP4296781B2 (en) 2001-04-24 2009-07-15 味の素株式会社 Stem cells and methods for separating them
CA2447015A1 (en) 2001-05-15 2002-11-21 Rappaport Family Institute For Research In The Medical Sciences Insulin producing cells derived from human embryonic stem cells
US6626950B2 (en) 2001-06-28 2003-09-30 Ethicon, Inc. Composite scaffold with post anchor for the repair and regeneration of tissue
KR100418195B1 (en) 2001-07-05 2004-02-11 주식회사 우리기술 Apparatus and method for multi-testing insulation of power cables
GB0117583D0 (en) 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
WO2003014313A2 (en) * 2001-08-06 2003-02-20 Bresagen, Ltd. Alternative compositions and methods for the culture of stem cells
US6617152B2 (en) * 2001-09-04 2003-09-09 Corning Inc Method for creating a cell growth surface on a polymeric substrate
KR20040054699A (en) * 2001-10-02 2004-06-25 엥스띠뛰 끌레이톤 드 라 러쉐르쉬 Methods and compositions relating to restricted expression lentiviral vectors and their applications
WO2003033697A1 (en) 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
HUP0500699A3 (en) * 2001-11-09 2010-01-28 Artecel Sciences Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
EP1442115B9 (en) 2001-11-15 2009-12-16 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
KR20120003961A (en) * 2001-12-07 2012-01-11 사이토리 테라퓨틱스, 인크. Systems and methods for treating patients with processed lipoaspirate cells
AU2002218893A1 (en) 2001-12-21 2003-07-09 Thromb-X Nv Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
US20030162290A1 (en) 2002-01-25 2003-08-28 Kazutomo Inoue Method for inducing differentiation of embryonic stem cells into functioning cells
DE60319364T2 (en) 2002-05-08 2009-02-19 Janssen Pharmaceutica N.V. SUBSTITUTED PYRROLINS AS KINASE INHIBITORS
US20060003446A1 (en) * 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
JP2006512046A (en) 2002-05-28 2006-04-13 ベクトン・ディキンソン・アンド・カンパニー Methods for proliferation of human pancreatic acinar cells and transdifferentiation into insulin producing cells in vitro
BR0311821A (en) 2002-06-05 2005-04-05 Janssen Pharmaceutica Nv Bisindolyl maleimid derivatives as kinase inhibitors
GB0212976D0 (en) 2002-06-06 2002-07-17 Tonejet Corp Pty Ltd Ejection method and apparatus
CN1171991C (en) 2002-07-08 2004-10-20 徐如祥 Culture process of human nerve stem cell
US6877147B2 (en) * 2002-07-22 2005-04-05 Broadcom Corporation Technique to assess timing delay by use of layout quality analyzer comparison
US7838290B2 (en) * 2002-07-25 2010-11-23 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
EP1539930A4 (en) 2002-07-29 2006-08-09 Es Cell Int Pte Ltd Multi-step method for the differentiation of insulin positive, glucose
US20040063204A1 (en) 2002-08-14 2004-04-01 Lijun Yang Bone marrow cell differentiation
EP1539928A4 (en) 2002-09-06 2006-09-06 Amcyte Inc Cd56 positive human adult pancreatic endocrine progenitor cells
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US20040062753A1 (en) * 2002-09-27 2004-04-01 Alireza Rezania Composite scaffolds seeded with mammalian cells
AU2003285172A1 (en) 2002-11-08 2004-06-03 The Johns Hopkins University Human embryonic stem cell cultures, and compositions and methods for growing same
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
EP1567639A4 (en) 2002-12-05 2005-12-21 Technion Res & Dev Foundation Cultured human pancreatic islets, and uses thereof
JP4613069B2 (en) 2002-12-16 2011-01-12 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド Method for preparing feeder cell-free and xeno-free human embryonic stem cells and stem cell culture prepared using them
US20070155661A1 (en) 2003-02-14 2007-07-05 The Board Of Trustees Of The Leland Standord Junior University Methods and compositions for modulating the development of stem cells
US20070154981A1 (en) * 2003-02-14 2007-07-05 The Board Of Trustees Of The Leland Stanford Junior University Insulin-producing cells derived from stem cells
CA2520861A1 (en) 2003-03-27 2004-10-14 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
WO2004090110A2 (en) 2003-03-31 2004-10-21 Bresagen Inc. Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
US20090203141A1 (en) 2003-05-15 2009-08-13 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
EP1641914B1 (en) * 2003-06-27 2016-07-20 DePuy Synthes Products, Inc. Postpartum cells derived from placental tissue, and methods of making and using the same
IL161903A0 (en) 2003-07-17 2005-11-20 Gamida Cell Ltd Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
ITRM20030395A1 (en) 2003-08-12 2005-02-13 Istituto Naz Per Le Malattie Infettive Lazz CULTURE GROUND FOR MAINTENANCE, PROLIFERATION AND DIFFERENTIATION OF MAMMALIAN CELLS.
US7569385B2 (en) * 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
US7157275B2 (en) * 2003-08-15 2007-01-02 Becton, Dickinson And Company Peptides for enhanced cell attachment and growth
AU2004269395A1 (en) 2003-08-27 2005-03-10 Stemcells California, Inc. Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
JP2007515433A (en) * 2003-12-17 2007-06-14 アラーガン　インコーポレイテッド Methods of treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B
US20060030042A1 (en) 2003-12-19 2006-02-09 Ali Brivanlou Maintenance of embryonic stem cells by the GSK-3 inhibitor 6-bromoindirubin-3'-oxime
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US7704738B2 (en) 2003-12-23 2010-04-27 Cythera, Inc. Definitive endoderm
TWI334443B (en) * 2003-12-31 2010-12-11 Ind Tech Res Inst Method of single cell culture of undifferentiated human embryonic stem cells
WO2005065354A2 (en) 2003-12-31 2005-07-21 The Burnham Institute Defined media for pluripotent stem cell culture
WO2005071066A1 (en) 2004-01-23 2005-08-04 Board Of Regents, The University Of Texas System Methods and compositions for preparing pancreatic insulin secreting cells
GB2441530B (en) 2004-02-12 2009-09-23 Univ Newcastle Stem Cells
CN1950498A (en) 2004-03-10 2007-04-18 加利福尼亚大学董事会 Compositions and methods for growth of embryonic stem cells
WO2005097977A2 (en) 2004-04-01 2005-10-20 Wisconsin Alumni Research Foundation Differentiation of stem cells to endoderm and pancreatic lineage
JP4926946B2 (en) 2004-04-27 2012-05-09 ヴィアサイト，インコーポレイテッド PDX1-expressing endoderm
JP5687816B2 (en) 2004-07-09 2015-03-25 ヴィアサイト，インコーポレイテッド Methods for identifying factors for differentiating definitive endoderm
JP5102030B2 (en) 2004-08-13 2012-12-19 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド Compositions and methods for self-renewal and differentiation in human embryonic stem cells
US20080268533A1 (en) 2004-08-25 2008-10-30 University Of Georgia Research Foundation, Inc. Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
DE102004043256B4 (en) 2004-09-07 2013-09-19 Rheinische Friedrich-Wilhelms-Universität Bonn Scalable process for culturing undifferentiated stem cells in suspension
MX2007002389A (en) 2004-09-08 2009-02-12 Wisconsin Alumni Res Found Culturing human embryonic stem cells.
ES2383813T3 (en) 2004-09-08 2012-06-26 Wisconsin Alumni Research Foundation Embryonic stem cell culture and culture method
AU2006210955A1 (en) 2005-01-31 2006-08-10 Es Cell International Pte Ltd. Directed differentiation of embryonic stem cells and uses thereof
ES2627419T3 (en) 2005-03-04 2017-07-28 Lifescan, Inc. Adult stromal cells derived from the pancreas
GB0505970D0 (en) 2005-03-23 2005-04-27 Univ Edinburgh Culture medium containing kinase inhibitor, and uses thereof
EP1876893B1 (en) 2005-04-15 2012-04-11 Geron Corporation Cancer treatment by combined inhibition of proteasome and telomerase activities
EP1874367B1 (en) 2005-04-26 2011-07-06 Arhus Universitet Biocompatible material for surgical implants and cell guiding tissue culture surfaces
MX2007015610A (en) 2005-06-10 2008-02-21 Irm Llc Compounds that maintain pluripotency of embryonic stem cells.
WO2006138433A2 (en) 2005-06-14 2006-12-28 The Regents Of The University Of California Induction of cell differentiation by class i bhlh polypeptides
EP1931764A1 (en) 2005-06-21 2008-06-18 GE Healthcare Bio-Sciences AB Method for cell culture
NZ564179A (en) 2005-06-30 2010-09-30 Janssen Pharmaceutica Nv Cyclic anilino - pyridinotriazines as GSK-3 inhibitors
US20080194021A1 (en) 2005-07-29 2008-08-14 Mays Robert W Use of a Gsk-3 Inhibitor to Maintain Potency of Culture Cells
CA2616863A1 (en) 2005-07-29 2007-02-01 Australian Stem Cell Centre Limited Compositions and methods for growth of pluripotent cells
KR20080056181A (en) 2005-09-02 2008-06-20 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Method of deriving progenitor cell line
GB2444686B (en) 2005-09-12 2010-08-25 Es Cell Int Pte Ltd Differentiation of pluripotent stem cells using p38 MAPK inhibitors or prostaglandins
CN101310012B (en) 2005-10-14 2012-05-09 明尼苏达大学董事会 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US20070122905A1 (en) 2005-10-27 2007-05-31 D Amour Kevin A PDX1-expressing dorsal and ventral foregut endoderm
WO2007082963A1 (en) 2006-01-18 2007-07-26 Fundación Instituto Valenciano De Infertilidad Human embryo stem-cell lines and methods for using same
EP1994141B1 (en) 2006-02-23 2017-11-15 ViaCyte, Inc. Compositions and methods useful for culturing differentiable cells
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
WO2007103282A2 (en) * 2006-03-02 2007-09-13 Cythera, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
CA2650812C (en) 2006-04-28 2017-12-12 Lifescan, Inc. Differentiation of human embryonic stem cells
US8741643B2 (en) 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
US20070259423A1 (en) * 2006-05-02 2007-11-08 Jon Odorico Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
WO2007139929A2 (en) 2006-05-25 2007-12-06 The Burnham Institute For Medical Research Methods for culture and production of single cell populations of human embryonic stem cells
US8415153B2 (en) 2006-06-19 2013-04-09 Geron Corporation Differentiation and enrichment of islet-like cells from human pluripotent stem cells
CN100494359C (en) 2006-06-23 2009-06-03 中日友好医院 Method for in vitro amplifying and in 3D solid culturing for nerve stem cell
EP2046946B8 (en) 2006-06-26 2017-01-25 Lifescan, Inc. Pluripotent stem cell culture
US20080003676A1 (en) 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
US8968994B2 (en) 2006-07-06 2015-03-03 Jeremy Micah Crook Method for stem cell culture and cells derived therefrom
AU2007277364B2 (en) 2006-07-26 2010-08-12 Viacyte, Inc. Methods of producing pancreatic hormones
JP2008099662A (en) 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research Method for culturing stem cell
US20080091234A1 (en) * 2006-09-26 2008-04-17 Kladakis Stephanie M Method for modifying a medical implant surface for promoting tissue growth
US20100323442A1 (en) 2006-10-17 2010-12-23 Emmanuel Edward Baetge Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells
CA2666789C (en) 2006-10-18 2016-11-22 Yong Zhao Embryonic-like stem cells derived from adult human peripheral blood and methods of use
TW200836749A (en) 2007-01-09 2008-09-16 Vioquest Pharmaceuticals Inc Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
CN103627671A (en) 2007-01-30 2014-03-12 佐治亚大学研究基金会 Method for generating endoderm and mesoderm lineages and multipotent migratory cells (MMC), and cell population and use
GB0703188D0 (en) 2007-02-19 2007-03-28 Roger Land Building Large scale production of stem cells
EP3957716A1 (en) * 2007-07-18 2022-02-23 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
EP2185693B1 (en) 2007-07-31 2019-07-03 Lifescan, Inc. Differentiation of human embryonic stem cells
KR101544498B1 (en) 2007-08-24 2015-08-17 스티칭 허트 네덜란드 칸커 인스티튜트 Compositions for the treatment of neoplastic diseases
US9062290B2 (en) 2007-11-27 2015-06-23 Lifescan, Inc. Differentiation of human embryonic stem cells
SG154367A1 (en) 2008-01-31 2009-08-28 Es Cell Int Pte Ltd Method of differentiating stem cells
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
MX2010009251A (en) 2008-02-21 2010-11-25 Centocor Ortho Biotech Inc Methods, surface modified plates and compositions for cell attachment, cultivation and detachment.
EP2479260B1 (en) 2008-03-17 2016-01-06 Agency For Science, Technology And Research Microcarriers for stem cell culture
DK2283117T3 (en) 2008-04-21 2014-01-20 Viacyte Inc PROCEDURE FOR CLEANING PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS
US20090298178A1 (en) 2008-06-03 2009-12-03 D Amour Kevin Allen Growth factors for production of definitive endoderm
DE102008032236A1 (en) 2008-06-30 2010-04-01 Eberhard-Karls-Universität Tübingen Isolation and / or identification of stem cells with adipocytic, chondrocytic and pancreatic differentiation potential
ES2697798T3 (en) 2008-06-30 2019-01-28 Janssen Biotech Inc Differentiation of pluripotent stem cells
US20100028307A1 (en) 2008-07-31 2010-02-04 O'neil John J Pluripotent stem cell differentiation
CA2742268C (en) 2008-10-31 2020-02-18 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
GB2485113B (en) 2009-07-20 2016-12-28 Janssen Biotech Inc Differentiation of human embryonic stem cells into cells of the pancreatic endoderm lineage
SG10201501513TA (en) 2010-03-02 2015-04-29 Univ Singapore Culture additives to boost stem cell proliferation and differentiation response

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054102A1 (en) * 2001-04-19 2005-03-10 Anna Wobus Method for differentiating stem cells into insulin-producing cells
US20030138948A1 (en) * 2001-12-07 2003-07-24 Fisk Gregory J. Islet cells from human embryonic stem cells
US20050208029A1 (en) * 2002-04-17 2005-09-22 Akihiro Umezawa Method of forming pancreatic beta cells from mesenchymal cells
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
US20060281174A1 (en) * 2004-03-09 2006-12-14 Gang Xu Methods for generating insulin-producing cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2456858A4 *

Also Published As

Publication number Publication date
CN102482640B (en) 2015-03-11
AU2010276440B2 (en) 2014-07-03
KR101893021B1 (en) 2018-08-29
EP2456858B1 (en) 2018-08-29
MX340952B (en) 2016-07-29
GB2485112B (en) 2014-02-26
MX2012000899A (en) 2012-02-13
HK1170262A1 (en) 2013-02-22
ES2693088T3 (en) 2018-12-07
JP2012533321A (en) 2012-12-27
BR112012001557A2 (en) 2016-03-08
CA2768644A1 (en) 2011-01-27
RU2540021C2 (en) 2015-01-27
EP2456858A2 (en) 2012-05-30
EP2456858A4 (en) 2015-03-18
AR077767A1 (en) 2011-09-21
PL2456858T3 (en) 2019-01-31
CN102482640A (en) 2012-05-30
WO2011011302A2 (en) 2011-01-27
KR20170117231A (en) 2017-10-20
GB201202847D0 (en) 2012-04-04
KR101785626B1 (en) 2017-10-16
US20110014702A1 (en) 2011-01-20
RU2012105923A (en) 2013-08-27
JP5819825B2 (en) 2015-11-24
KR20120034793A (en) 2012-04-12
ZA201201221B (en) 2013-07-31
SG177483A1 (en) 2012-02-28
US8785184B2 (en) 2014-07-22
AU2010276440A1 (en) 2012-01-19
GB2485112A (en) 2012-05-02

Similar Documents

Publication Publication Date Title
WO2011011302A3 (en) Differentiation of human embryonic stem cells
HK1247954A1 (en) Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
WO2012030539A3 (en) Differentiation of human embryonic stem cells
WO2011079018A3 (en) Differentiation of human embryonic stem cells
CA2860107C (en) Differentiation of human embryonic stem cells into single hormonal insulin positive cells
WO2012030538A3 (en) Differentiation of human embryonic stem cells
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
EP2639293A4 (en) Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same
WO2011011300A8 (en) Differentiation of human embryonic stem cells
WO2011003034A3 (en) Biological methods for preparing adipic acid
WO2012030540A3 (en) Differentiation of pluripotent stem cells
EP2438161B1 (en) Method for producing induced pluripotent stem cells and method for culturing the same
MY161726A (en) Biological methods for preparing adipic acid
MX349658B (en) Method for differentiation of pluripotent stem cells into vascular bed cells.
EP2374871A4 (en) Pluripotent stem cells, method for preparation thereof and uses thereof
WO2012135621A3 (en) Priming of pluripotent stem cells for neural differentiation
WO2012098537A8 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
EP2671945A4 (en) Method for culturing human pluripotent stem cells
EP2639297A4 (en) Method for producing peripheral blood monocyte-derived pluripotent stem cells
IL226617B (en) Insulin producing cells derived from pluripotent stem cells
WO2012087670A3 (en) Genetically engineered microorganisms comprising 4-hydroxybenzoyl-coa thioesterases and methods of using the same
EP2537920A4 (en) Method for production of artificial pluripotent stem cell
EP2778223A4 (en) Vascular progenitor cell sheet derived from induced pluripotent stem cells, and production method therefor
EP2615165A4 (en) Culture method related to differentiation of pluripotent stem cells into blood cells
WO2011117728A3 (en) Novel cbh1-eg1 fusion proteins and use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080033697.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10802710

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010276440

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10333/DELNP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 12012500029

Country of ref document: PH

ENP Entry into the national phase

Ref document number: 2010276440

Country of ref document: AU

Date of ref document: 20100719

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012521699

Country of ref document: JP

Ref document number: 2768644

Country of ref document: CA

Ref document number: MX/A/2012/000899

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20127003776

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010802710

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 1202847

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20100719

WWE Wipo information: entry into national phase

Ref document number: 2012105923

Country of ref document: RU

Ref document number: 1202847.8

Country of ref document: GB

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012001557

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012001557

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120123